Ivacaftor + Tezacaftor

Category: Genetic Disorders

Ivacaftor + Tezacaftor Overview

Tezacaftor, development code VX-661, is a drug that is sold as a fixed-dose combination with ivacaftor as Symdeko. It is used for the treatment of cystic fibrosis (CF) in people six years and older, who have specific gene mutations.[1][2] In 2018, the U.S. Food and Drug Administration (FDA) approved a combination of ivacaftor and tezacaftor;[1] the manufacturer announced a list price of $292,000 per year.[3] The combination of iv...

Read more Ivacaftor + Tezacaftor Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tezacaftor

Recent Ivacaftor + Tezacaftor Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ivacaftor + Tezacaftor
  • Tablet, Tablet: 150mg,n/a + 150mg, 100mg, 75mg,n/a + 75mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (7 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA